What "margin clearance" means

The pathologist measures the distance of normal tissue between the tumour's edge and the cut edge of the specimen (lateral and deep margins). Reports describe this as adequate (clear), narrow (close), or inadequate/involved (tumour cells seen at the margin itself).

⚠️ Histology typically samples only a fraction of the tumour border — sometimes as little as 1% — so a "clear" report is informative, not an absolute guarantee the whole margin is tumour-free.

Basal cell carcinoma (BCC)

Margin resultRisk tierAction
Adequate / clearAnyNo further surgery — routine annual skin check follow-up (low-risk). High-risk: review every 6 months in year 1, then annually.
Narrow / closeAnyClose monitoring; consider further surgery or adjunctive therapy depending on how narrow and the tumour's risk features.
Inadequate / involvedLow-riskRe-excise in general practice. Radiotherapy an option in select cases; persistent superficial BCC may sometimes be managed with topical imiquimod instead.
Inadequate / involvedHigh-risk, or recurrent with unclear original marginsRefer to a specialist — Mohs surgery may be considered, especially where original tumour edges are hard to define.

Reported recurrence for low-risk BCC with a clinical excision margin of 5/4/3/2mm: approximately 0.4% / 1.6% / 2.6% / 4%. Recurrence rises sharply with an involved histological margin — reported figures range from roughly 12–38% depending on the series.

Squamous cell carcinoma (SCC)

Margin resultRisk tierAction
≥1mm histological marginLow-riskNo further surgery — annual skin check follow-up.
<1mm histological marginLow-riskRe-excise.
Inadequate margin, or perineural invasionHigh-risk (esp. head/neck)Refer. Perineural invasion also warrants MRI regardless of margin status.

Clinical (pre-excision) margin targets: 3–4mm for BCC, at least 4mm for low-risk SCC. High-risk SCC has no single published clinical margin target — refer early if uncertain. Follow-up after complete excision of high-risk SCC: review at 3 months, then every 6 months, including examination of the draining lymph node basin.

Melanoma

A diagnostic excision biopsy of a clinically suspected melanoma uses a narrow margin (~2mm) purely to confirm the diagnosis histologically. Once melanoma is confirmed, a wide local excision (WLE) is required as a separate procedure regardless of how clear the original biopsy margin was — the WLE margin is set by Breslow thickness, not by re-reading the diagnostic biopsy margin.

📏 Full WLE margins by Breslow thickness (in situ through >4mm) are on the Skin Excision MBS page, under "NHMRC margin guidelines" — and the Excision Margin Calculator will give you the margin and MBS item together.

Usually safe to re-excise yourself: low-risk BCC with an involved/inadequate margin; low-risk SCC with <1mm histological margin.

Refer: high-risk BCC or SCC with an inadequate margin; recurrent BCC/SCC, especially where the original tumour edges are hard to define; any tumour with perineural invasion; confirmed melanoma requiring wide local excision beyond your comfort or scope.

"Risk tier" (low vs high-risk) depends on site, size, histological subtype, and clinical features — see the Cancer Council Australia keratinocyte cancer guidelines for the full risk-stratification criteria if a lesion doesn't clearly fit either category.

You might also like
Clinical references current as at October 2026. Always cross-check against current Cancer Council Australia / RACGP keratinocyte cancer and melanoma guidelines for your specific case.